Home > Items where lead contributor is Advisory Council on the Misuse of Drugs

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Jump to: Report
Number of items: 23.

Report

Advisory Council on the Misuse of Drugs. (2024) A review of the evidence on the use and harms of xylazine, medetomidine and detomidine. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2023) Nitrous oxide – updated harms assessment. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2023) Cumyl-PeGaClone and other recently encountered synthetic cannabinoid receptor agonists. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2023) A review of the evidence on the use and harms of Diphenidine and other related substances. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2023) Drug Science submits evidence to the ACMD nitrous oxide review. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2022) ACMD advice on the classification and schedule of Remimazolam. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2022) ACMD report – A review of the evidence on the use and harms of 2-benzyl benzimidazole (‘nitazene’) and piperidine benzimidazolone (‘brorphine-like’) opioids. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2022) ACMD review of the UK naloxone implementation. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2022) Drug misuse prevention review. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2020) An assessment of the harms of gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and closely related compounds. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2020) Synthetic cannabinoid receptor agonists (SCRA). An updated harms assessment and a review of classification and scheduling under the Misuse of Drugs Act 1971 and its Regulations. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2020) Novel benzodiazepines: a review of the evidence of use and harms of novel benzodiazepines. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2020) Standard Operating Procedure for using evidence in ACMD reports. London: Home Office.

Advisory Council on the Misuse of Drugs. (2019) ACMD report - Ageing cohort of drug users. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2019) ACMD report on Custody-Community Transitions (CCT). London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2019) Drug-related harms in homeless populations and how they can be reduced. Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2016) Reducing opioid-related deaths in the UK. London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2013) What recovery outcomes does the evidence tell us we can expect? London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs. (2011) Consideration of the novel psychoactive substances (‘legal highs’). London: Advisory Council on the Misuse of Drugs.

Advisory Council on the Misuse of Drugs, Royal College of Psychiatrists, Royal College of General Practitioners, British Pain Society. (2007) Pain and substance misuse: improving the patient experience. London: The British Pain Society.

Advisory Council on the Misuse of Drugs. (2003) Hidden harm: responding to the needs of children of problem drug users. London: Home Office.

Advisory Council on the Misuse of Drugs. (2000) Reducing drug related deaths: a report by the Advisory Council on the Misuse of Drugs. London: Stationery Office.

Advisory Council on the Misuse of Drugs. (1998) Drug misuse and the environment: a report by the Advisory Council on the Misuse of Drugs. London: Stationery Office.

This list was generated on Thu Mar 28 03:41:57 2024 GMT.